CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
Oncogene
; 36(28): 4081-4086, 2017 07 13.
Article
in En
| MEDLINE
| ID: mdl-28263973
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligodeoxyribonucleotides
/
B-Lymphocytes
/
Antineoplastic Combined Chemotherapy Protocols
/
Cancer Vaccines
/
Proto-Oncogene Proteins B-raf
/
Protein Kinase Inhibitors
/
Melanoma
Limits:
Animals
Language:
En
Journal:
Oncogene
Year:
2017
Document type:
Article